In addition, the direct binding of miR-29c to the wild-type 3′UTR of DNTM3B indicates that miR-29c is the direct post-transcriptional regulator of DNMT3B, which is elevated in breast cancer and methylates the promoter of the TIMP3 gene. This evidence concerns the gene TIMP3 and breast carcinoma.